MARKET OVERVIEW:

The global biopreservation market was valued at USD 8.5 billion in 2024 and is projected to reach USD 20.0 billion by 2033, growing at a CAGR of 9.98% from 2025 to 2033. The market is driven by the rising focus on personalized medicine, increased research and development (R&D) investments, and heightened awareness of rare diseases. These factors collectively drive the demand for biopreservation techniques in fields like regenerative medicine, drug development, and clinical research.

STUDY ASSUMPTION YEARS:

• BASE YEAR: 2024
• HISTORICAL YEAR: 2019-2024
• FORECAST YEAR: 2025-2033

BIOPRESERVATION MARKET KEY TAKEAWAYS:

• The biopreservation market is expected to grow from USD 8.5 billion in 2024 to USD 20.0 billion by 2033 at a CAGR of 9.98%.
• The demand for biobanking and personalized healthcare fuels market growth.
• Advancements in regenerative medicine and stem cell storage enhance the market outlook.
• Biopharmaceutical companies' growing reliance on preservation techniques drives the market.
• Biopreservation equipment holds the largest market share.
• Increasing awareness of rare diseases boosts biological sample preservation.
• Technological innovations in cryopreservation and storage methods contribute to market expansion.

MARKET GROWTH FACTORS:

Rising Demand for Biobanking:

Biobanks are facilities that preserve biological specimens meant for research and clinical applications. That is to say, biobanks are indispensable for genomic studies, precision medicine, and personalized healthcare. As more demand arises for large-scale population studies or clinical trials, biobanks are coming to the forefront with the utmost importance in biopreservation. The preservation of such specimens will ease research into rare diseases and genetic disorders that will consequently lead to the development of targeted therapies and diagnostic measures.

Advancements in Regenerative Medicine:

Biopreservation of cells being used in regenerative medicine to restore or replace damaged tissues is vital to these therapies' success in cell viability and functionality. So, the techniques of cryopreservation and storage of stem cells constitute the very foundation for cell potency preservation and thus therapeutic advancement. Thus, regenerative medicine could become the driver of demand for advanced biopreservation techniques in marginally increasing demand for better cryoprotectants.

Growth of the Biopharmaceutical Industry:

The growth of the biopharmaceutical industry particularly advances into the area of biological drug production and strongly affects the need for biopreservation methods. Biological drugs such as therapeutic proteins and vaccines are extremely sensitive to environmental conditions, requiring optimal conditions for preservation, safety, and stability. To prolong the shelf life of these sensitive products, biopreservation is achieved through cryopreservation, lyophilization, and chemical fixation. This is necessary in ensuring the practical use of biological products regarding their potency and safety.

MARKET SEGMENTATION:

• Breakup by Product Type:
  • Biopreservation Equipment: Essential for preserving biological materials using various techniques like cryopreservation and lyophilization.
  • Biopreservation Media: Includes the substances used to maintain biological integrity during preservation.
• Breakup by Application:
  • Therapeutic Applications: Used for the preservation of biological samples in clinical therapies.
  • Biobank Applications: Involves the storage of biological samples for research and diagnostics.
  • Drug Discovery Applications: Supports the preservation of samples in drug development and testing processes.
• Breakup by Region:
  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

REGIONAL INSIGHTS:

The established North America market for biopreservation stands preeminent across the globe since there is a formidable concentration of institutions, pharmaceutical companies, and biobanks. The U.S. section of the market is specifically buoyed by developments in personalized medicine and a generally high level of R&D investment within biotechnology and healthcare. A strong healthcare infrastructure and emerging demand for regenerative medicines bodes well for the region's major market share.

RECENT DEVELOPMENTS & NEWS:

Much innovation in recent biopreservation was triggered by the development of a new class of cryoprotectants and automated storage systems that ensure that biological materials are well preserved and functional after thawing. Many efforts are being put into upgrading biobanking infrastructure for more efficient collection and storage of biological samples. These marketing innovations are meant to maintain sample integrity within the biobanking sector while supporting advancements in regenerative medicine and drug discovery.

KEY PLAYERS:

• BioLife Solutions, Inc.
• Thermo Fisher Scientific Inc.
• VWR International, LLC
• Panasonic Corporation
• BioCision LLC

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, considerations studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.